Recombinant human activated protein C as a disease modifier in severe acute pancreatitis: Systematic review of current evidence

The experimental evidence of disease amelioration in AP following intervention with rhAPC has not translated to the small clinical RCT. Given that there were only 16 patients in the treatment arm, further clinical evaluation is justified.